Alcobra up after pricing offering

• Investors in thinly-traded nano cap Alcobra (ADHD +24.7%) ignore the discount on the pricing of its public offering of 6.5M shares of common stock at $4 per share by bidding up the price on quadruple normal volume. Underwriters over-allotment is 975K shares. Closing date is January 14.
• Adamis Pharma could use some of Alcobra's sauce.
• Previously: Adamis plummets after pricing offering at a discount (Jan. 9)